- Home
- TLSI vs FNGR Comparison
TLSI vs FNGR Comparison
Compare TLSI & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | FNGR |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 81.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | FNGR |
|---|---|---|
| Price | $5.91 | $1.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | 212.5K | ★ 229.7K |
| Earning Date | 11-13-2025 | 01-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,207,000.00 | $35,881,122.00 |
| Revenue This Year | $55.06 | N/A |
| Revenue Next Year | $46.04 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.52 | 15.09 |
| 52 Week Low | $3.42 | $1.10 |
| 52 Week High | $7.95 | $5.20 |
Technical Indicators
Market Signals| Indicator | TLSI | FNGR |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 44.69 |
| Support Level | $5.60 | $1.22 |
| Resistance Level | $7.20 | $1.38 |
| Average True Range (ATR) | 0.48 | 0.08 |
| MACD | -0.23 | -0.02 |
| Stochastic Oscillator | 12.98 | 33.33 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.